-- Eric M Dube, Director and Chief Executive Officer, on May 04, 2026, sold 22,500 shares in Travere Therapeutics (TVTX) for $988,875. Following the Form 4 filing with the SEC, Dube has control over a total of 432,886 common shares of the company, with 432,886 shares held directly.
SEC Filing: